PRILOSEC - Dosage Omeprazole magnesium
Dosage & Administration
recommended adult dosage regimen by indication
Table 1 shows the recommended dosage of PRILOSEC in adult patients by indication.
Indication | Dosage of PRILOSEC | Treatment Duration |
---|---|---|
Treatment of Active Duodenal Ulcer | 20 mg once daily | 4 weeks Most patients heal within 4 weeks; some patients may require an additional 4 weeks of therapy to achieve healing |
Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence | Triple Therapy PRILOSEC 20 mg Amoxicillin 1000 mg Clarithromycin 500 mg Take all three drugs twice daily | 10 days In patients with an ulcer present at the time of initiation of therapy, continue PRILOSEC 20 mg once daily for an additional 18 days for ulcer healing and symptom relief. |
Dual Therapy PRILOSEC 40 mg once daily Clarithromycin 500 mg three times daily | 14 days In patients with an ulcer present at the time of initiation of therapy, an additional 14 days of PRILOSEC 20 mg once daily is recommended for ulcer healing and symptom relief. | |
Active Benign Gastric Ulcer | 40 mg once daily | 4 to 8 weeks |
Treatment of Symptomatic GERD | 20 mg once daily | Up to 4 weeks |
Treatment of EE due to Acid-Mediated GERD | 20 mg once daily | 4 to 8 weeks The efficacy of PRILOSEC used for longer than 8 weeks in patients with EE has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of EE or GERD symptoms (e.g., heartburn), additional 4 to 8 week courses of PRILOSEC may be considered. |
Maintenance of Healing of EE due to Acid-Mediated GERD | 20 mg once daily | Controlled studies do not extend beyond 12 months. |
Pathological Hypersecretory Conditions | Starting dose is 60 mg once daily; adjust to patient needs Daily dosages of greater than 80 mg should be administered in divided doses. Dosages up to 120 mg three times daily have been administered. | As long as clinically indicated. Some patients with Zollinger-Ellison syndrome have been treated continuously for more than 5 years. |
recommended pediatric dosage regimen by indication
Table 2 shows the recommended dosage of PRILOSEC in pediatric patients by indication.
Indication | PRILOSEC Dosage Regimen and Duration | ||
Patient Age | Weight-Based Dose (mg) | Regimen and Duration | |
Treatment of Symptomatic GERD | 1 to 16 years | 5 to less than 10 kg: 5 mg | Once daily for up to 4 weeks |
10 to less than 20 kg: 10 mg | |||
20 kg and greater: 20 mg | |||
Treatment of EE due to Acid-Mediated GERD | 1 to 16 years | 5 to less than 10 kg: 5 mg | Once daily for 4 to 8 weeks The efficacy of PRILOSEC used for longer than 8 weeks in patients with EE has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of EE or GERD symptoms (e.g., heartburn), additional 4 to 8 week courses of PRILOSEC may be considered. |
10 to less than 20 kg: 10 mg | |||
20 kg and greater: 20 mg | |||
1 month to less than 1 year | 3 to less than 5 kg: 2.5 mg | Once daily up to 6 weeks | |
5 to less than 10 kg: 5 mg | |||
10 kg and greater: 10 mg | |||
Maintenance of Healing of EE due to Acid-Mediated GERD | 1 to 16 years | 5 to less than 10 kg: 5 mg | Once daily. Controlled studies do not extend beyond 12 months |
10 to less than 20 kg: 10 mg | |||
20 kg and greater: 20 mg |
administration instructions
- Take PRILOSEC before meals.
- Antacids may be used concomitantly with PRILOSEC.
- Missed doses: If a dose is missed, administer as soon as possible. However, if the next scheduled dose is due, do not take the missed dose, and take the next dose on time. Do not take two doses at one time to make up for a missed dose.
PRILOSEC Delayed-Release Capsules
- Swallow PRILOSEC delayed-release capsules whole; do not chew.
- For patients unable to swallow an intact capsule, PRILOSEC delayed-release capsules can be opened and administered as follows:
- 1.Place one tablespoon of applesauce into a clean container (e.g., empty bowl). The applesauce used should not be hot and should be soft enough to be swallowed without chewing.
- 2.Open the capsule.
- 3.Carefully empty all of the pellets inside the capsule on the applesauce.
- 4.Mix the pellets with the applesauce.
- 5.Swallow applesauce and pellets immediately with a glass of cool water to ensure complete swallowing of the pellets. Do not chew or crush the pellets. Do not save the applesauce and pellets for future use.
PRILOSEC For Delayed-Release Oral Suspension
PRILOSEC for delayed-release oral suspension is intended to be prepared in water and administered orally or via a nasogastric (NG) or gastric tube.
Oral Administration in Water
- 1.Empty the contents of a 2.5 mg packet into a container containing 5 mL of water.
- 2.Empty the contents of a 10 mg packet into a container containing 15 mL of water.
- 3.Stir.
- 4.Leave 2 to 3 minutes to thicken.
- 5.Stir and drink within 30 minutes.
- 6.If any material remains after drinking, add more water, stir and drink immediately.
Administration with Water via a NG or Gastric Tube (Size 6 or Larger)
- 1.Add 5 mL of water to a catheter tipped syringe and then add the contents of a 2.5 mg packet (or 15 mL of water for the 10 mg packet). It is important to only use a catheter tipped syringe when administering through a nasogastric tube or gastric tube.
- 2.Immediately shake the syringe and leave 2 to 3 minutes to thicken.
- 3.Shake the syringe and inject through the nasogastric or gastric tube into the stomach within 30 minutes.
- 4.Refill the syringe with an equal amount of water.
- 5.Shake and flush any remaining contents from the nasogastric or gastric tube into the stomach.
Dosage Form & Strengths
PRILOSEC Delayed-Release Capsules
- 10 mg, are opaque, hard gelatin, apricot and amethyst colored capsules, coded 606 on cap and PRILOSEC 10 on the body.
- 20 mg, are opaque, hard gelatin, amethyst colored capsules, coded 742 on cap and PRILOSEC 20 on the body.
- 40 mg, are opaque, hard gelatin, apricot and amethyst colored capsules, coded 743 on cap and PRILOSEC 40 on the body.
PRILOSEC For Delayed-Release Oral Suspension
- 2.5 mg and 10 mg unit dose packets containing a fine yellow powder, consisting of white to brownish omeprazole granules and pale yellow inactive granules.
Overdosage
Reports have been received of overdosage with omeprazole in humans. Doses ranged up to 2400 mg (120 times the usual recommended clinical dose). Manifestations were variable, but included confusion, drowsiness, blurred vision, tachycardia, nausea, vomiting, diaphoresis, flushing, headache, dry mouth, and other adverse reactions similar to those seen in normal clinical experience [see Adverse Reactions (6)]. Symptoms were transient, and no serious clinical outcome has been reported when PRILOSEC was taken alone. No specific antidote for omeprazole overdosage is known. Omeprazole is extensively protein bound and is, therefore, not readily dialyzable. In the event of overdosage, treatment should be symptomatic and supportive.
If over-exposure occurs, call your Poison Control Center at 1-800-222-1222 for current information on the management of poisoning or overdosage.
Storage & Handling
PRILOSEC delayed-release capsules, 10 mg, are opaque, hard gelatin, apricot and amethyst colored capsules, coded 606 on cap and PRILOSEC 10 on the body. They are supplied as follows:
NDC 0186-0606-31 unit of use bottles of 30
PRILOSEC delayed-release capsules, 20 mg, are opaque, hard gelatin, amethyst colored capsules, coded 742 on cap and PRILOSEC 20 on body. They are supplied as follows:
NDC 0186-0742-31 unit of use bottles of 30
NDC 0186-0742-82 bottles of 1000
PRILOSEC delayed-release capsules, 40 mg, are opaque, hard gelatin, apricot and amethyst colored capsules, coded 743 on cap and PRILOSEC 40 on the body. They are supplied as follows:
NDC 0186-0743-31 unit of use bottles of 30
NDC 0186-0743-68 bottles of 100
PRILOSEC for delayed-release oral suspension, 2.5 mg or 10 mg, is supplied as a unit dose packet containing a fine yellow powder, consisting of white to brownish omeprazole granules and pale yellow inactive granules. PRILOSEC unit dose packets are supplied as follows:
NDC 0186-0625–01 unit dose packages of 30: 2.5 mg packets
NDC 0186-0610–01 unit dose packages of 30: 10 mg packets
Storage
Store PRILOSEC delayed-release capsules in a tight container protected from light and moisture. Store between 15°C and 30°C (59°F and 86°F).
Store PRILOSEC for delayed-release oral suspension at 25°C (77°F); excursions permitted to 15 – 30°C (59 – 86°F). [See USP Controlled Room Temperature.]
Or Browse by Name
At Healthgrades, our Editorial Team works hard to develop complete, objective and meaningful health information to help people choose the right doctor, right hospital and right care. Our writers include physicians, pharmacists, and registered nurses with firsthand clinical experience. All condition, treatment and wellness content is medically reviewed by at least one medical professional ensuring the most accurate information possible. Learn more about our editorial process.